1-[(S)-2-(Pyrrolidine-1-carbonyl)-pyrrolidin-1-yl]-octan-1-one

ID: ALA298028

Chembl Id: CHEMBL298028

PubChem CID: 10085837

Max Phase: Preclinical

Molecular Formula: C17H30N2O2

Molecular Weight: 294.44

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCC(=O)N1CCC[C@H]1C(=O)N1CCCC1

Standard InChI:  InChI=1S/C17H30N2O2/c1-2-3-4-5-6-11-16(20)19-14-9-10-15(19)17(21)18-12-7-8-13-18/h15H,2-14H2,1H3/t15-/m0/s1

Standard InChI Key:  FNZKDUXXKIFDBI-HNNXBMFYSA-N

Associated Targets(non-human)

Prep Prolyl endopeptidase (113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 294.44Molecular Weight (Monoisotopic): 294.2307AlogP: 2.96#Rotatable Bonds: 7
Polar Surface Area: 40.62Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.48CX LogD: 2.48
Aromatic Rings: Heavy Atoms: 21QED Weighted: 0.68Np Likeness Score: -0.80

References

1. Karoly K, Sandor E, Edit S, Miklos F, Judit S, Benjamin P, Andrea S, Istvan H.  (1997)  Prolyl endopeptidase inhibitors1: N-acyl derivatives of L-thioproline-pyrrolidine,  (13): [10.1016/S0960-894X(97)00295-3]
2. Kánai K, Arányi P, Böcskei Z, Ferenczy G, Harmat V, Simon K, Bátori S, Náray-Szabo G, Hermecz I..  (2008)  Prolyl oligopeptidase inhibition by N-acyl-pro-pyrrolidine-type molecules.,  51  (23): [PMID:19006380] [10.1021/jm800944x]
3. Lawandi J, Gerber-Lemaire S, Juillerat-Jeanneret L, Moitessier N..  (2010)  Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors.,  53  (9): [PMID:20058865] [10.1021/jm901104g]

Source